T. Rowe Price Associates’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08M Sell
859,874
-84,999
-9% -$338K ﹤0.01% 1638
2025
Q4
$3.32M Sell
944,873
-116,422
-11% -$399K ﹤0.01% 1542
2025
Q3
$3.46M Sell
1,061,295
-38,534
-4% -$121K ﹤0.01% 1515
2025
Q2
$2.7M Sell
1,099,829
-1,943,853
-64% -$9.85M ﹤0.01% 1517
2025
Q1
$20.3M Sell
3,043,682
-104,838
-3% -$1.04M ﹤0.01% 950
2024
Q4
$39.6M Sell
3,148,520
-59,261
-2% -$892K ﹤0.01% 820
2024
Q3
$59.2M Buy
3,207,781
+38,333
+1% +$785K 0.01% 709
2024
Q2
$68.2M Buy
3,169,448
+226,288
+8% +$5.2M 0.01% 622
2024
Q1
$79.3M Buy
2,943,160
+314,086
+12% +$8.92M 0.01% 599
2023
Q4
$78.8M Sell
2,629,074
-8,877
-0.3% -$196K 0.01% 590
2023
Q3
$54.1M Buy
2,637,951
+519,145
+25% +$9.44M 0.01% 660
2023
Q2
$42.1M Buy
2,118,806
+251,824
+13% +$5.09M 0.01% 750
2023
Q1
$32M Sell
1,866,982
-19,308
-1% -$378K ﹤0.01% 805
2022
Q4
$36.9M Buy
1,886,290
+246,647
+15% +$4.54M 0.01% 749
2022
Q3
$26.2M Buy
1,639,643
+232,294
+17% +$3.62M ﹤0.01% 829
2022
Q2
$19.4M Sell
1,407,349
-1,095,037
-44% -$13.1M ﹤0.01% 1173
2022
Q1
$39.7M Buy
2,502,386
+309,492
+14% +$5.35M ﹤0.01% 1049
2021
Q4
$47.9M Sell
2,192,894
-691,532
-24% -$18.9M ﹤0.01% 1024
2021
Q3
$86.2M Sell
2,884,426
-468,259
-14% -$17M 0.01% 816
2021
Q2
$148M Sell
3,352,685
-246,150
-7% -$10.7M 0.01% 652
2021
Q1
$160M Buy
3,598,835
+119,514
+3% +$6.56M 0.02% 623
2020
Q4
$191M Buy
3,479,321
+1,120,055
+47% +$40.8M 0.02% 540
2020
Q3
$53.9M Buy
2,359,266
+949,319
+67% +$23.4M 0.01% 841
2020
Q2
$29.5M Sell
1,409,947
-117,811
-8% -$2.12M ﹤0.01% 1017
2020
Q1
$21.3M Sell
1,527,758
-325,912
-18% -$6.45M ﹤0.01% 1052
2019
Q4
$42.2M Buy
1,853,670
+436,725
+31% +$7.29M 0.01% 972
2019
Q3
$16.5M Buy
1,416,945
+243,999
+21% +$3.03M ﹤0.01% 1204
2019
Q2
$17.6M Buy
1,172,946
+232,542
+25% +$4.06M ﹤0.01% 1212
2019
Q1
$16.5M Buy
940,404
+33,445
+4% +$528K ﹤0.01% 1233
2018
Q4
$13.4M Buy
906,959
+449,118
+98% +$7.46M ﹤0.01% 1254
2018
Q3
$11.3M Sell
457,841
-9,279
-2% -$201K ﹤0.01% 1352
2018
Q2
$9.17M Sell
467,120
-17,885
-4% -$338K ﹤0.01% 1359
2018
Q1
$9.09M Buy
485,005
+240,930
+99% +$3.93M ﹤0.01% 1352
2017
Q4
$2.55M Buy
+244,075
New +$2.42M ﹤0.01% 1536
2017
Q1
Sell
-236,445
Closed -$5.77M 2586
2016
Q4
$5.77M Buy
236,445
+1,675
+0.7% +$47.8K ﹤0.01% 1402
2016
Q3
$8.9M Buy
234,770
+52,662
+29% +$1.66M ﹤0.01% 1339
2016
Q2
$5.42M Sell
182,108
-125
-0.1% -$4.39K ﹤0.01% 1394
2016
Q1
$5.39M Sell
182,233
-1,533
-0.8% -$46K ﹤0.01% 1386
2015
Q4
$8.33M Sell
183,766
-3,725
-2% -$162K ﹤0.01% 1323
2015
Q3
$7.05M Buy
+187,491
New +$8.61M ﹤0.01% 1382

Other funds holding RCKT